Livzon Pharmaceutical Group's current cash is $7.2B.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Livzon Pharmaceutical Group (LVZPF) currently reports a current cash of $7.2B as of September 2026. That compares with $9.9B in the prior-year period — down 26.9% year over year. Use the charts on this page to explore Livzon Pharmaceutical Group's current cash history and peer comparisons.
Livzon Pharmaceutical Group's current cash decreased from $9.9B to $7.2B — a 26.9% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Livzon Pharmaceutical Group reported $7.2B in current cash as of September 2026. That compares with $9.9B in the prior-year period — down 26.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current current cash of $7.2B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Livzon Pharmaceutical Group, and consider following LVZPF for alerts when major investors trade the stock.